Dan Blackman

Interventional cardiologist / Cardiologist
Leeds General Infirmary - Leeds, United Kingdom

Latest contributions

TAVI for bioprosthetic valve failure - LIVE Case

22 May 2025 – From EuroPCR 2025

A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...

TAVI for bioprosthetic valve failure - LIVE Case

Redo TAVI - How to treat different TAVI platforms when they fail

22 May 2025 – From EuroPCR 2025

Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.

Redo TAVI - How to treat different TAVI platforms when they fail

TAV-in-TAV complications

21 May 2025 – From EuroPCR 2025

Focus on the complexities and challenges of TAV-in-TAV procedures in this session. Topics include planning valve-in-valve TAVI for aortic bioprosthetic valve regurgitation, managing anatomical challenges such as left ventricular outflow tract calcium and large annulus, and addressing severe bicuspid valve stenosis with impaired ventricular function. The...

TAV-in-TAV complications

Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

21 May 2025 – From EuroPCR 2025

Cerebral embolic protection (CEP) remains a key consideration in modern TAVI procedures, as stroke continues to be one of the most serious complications. This EuroPCR 2025 session takes a close look at the latest data on CEP use in clinical practice, weighing where it fits best...

Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

Challenges and solutions in an expanding TAVI world

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session addresses key challenges and emerging solutions in today’s rapidly evolving TAVI landscape. It presents the latest evidence on valve replacement in low-risk patients with aortic stenosis, alongside strategies for navigating the complexities of lifetime management in TAVI candidates. The programme features a...

Challenges and solutions in an expanding TAVI world